Literature DB >> 35732325

Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells.

Tin May Aung1, Atit Silsirivanit2,3, Apinya Jusakul1,3, Waraporn Chan-On4, Tanakorn Proungvitaya1, Sittiruk Roytrakul5, Siriporn Proungvitaya6,3.   

Abstract

BACKGROUND/AIM: Angiopoietin-like protein 4 (ANGPTL4) is a multifunctional signaling protein implicated in carbohydrate metabolism, inflammation, cancer growth and progression, anoikis resistance, angiogenesis, and metastasis. However, signaling pathways of ANGPTL4 in cholangiocarcinoma (CCA) remain unknown. The aim of this study was to explore ANGPTL4-related signaling proteins and pathways associated with CCA biology.
MATERIALS AND METHODS: ANGPTL4 of CCA cells was silenced by small interfering RNA (siRNA) with scramble control and ANGPTL4-related signaling proteins were investigated using mass spectrometry, bioinformatics tools and molecular docking.
RESULTS: Among the 321 differentially expressed proteins, 151 were down-regulated. Among them, bioinformatic analyses revealed that ANGPTL4 interacts with DNA-dependent protein kinase catalytic subunit (PRKDC) and 60S ribosomal protein L21 (RPL21) via AKT serine/threonine kinase 1 (AKT1), mechanistic target of rapamycin kinase (MTOR) and ribosomal protein L5 (RPL5). Online database analysis showed that mRNA and protein expression levels of ANGPTL4-related signaling proteins were significantly higher in CCA than in normal tissues. Moreover, a high mRNA expression level was associated with high tumor grade (p<0.0001) and lymph node metastasis (p<0.0001).
CONCLUSION: The signaling pathway of ANGPTL4 in CCA progression might be regulated by PRKDC and RPL21. Furthermore, high expression of ANGPTL4-related signaling proteins has potential to be used in clinical prognosis.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ANGPTL4; CCA; bioinformatics; mass spectrometry; signaling pathways

Mesh:

Substances:

Year:  2022        PMID: 35732325      PMCID: PMC9247875          DOI: 10.21873/cgp.20335

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   3.395


  52 in total

1.  Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT.

Authors:  Masanobu Maruyama; Naoya Kobayashi; Karen A Westerman; Masakiyo Sakaguchi; Jean E Allain; Toshinori Totsugawa; Teru Okitsu; Takuya Fukazawa; Anne Weber; Donna B Stolz; Philippe Leboulch; Noriaki Tanaka
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

2.  AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.

Authors:  Joanna C Chan; Katherine M Hannan; Kim Riddell; Pui Yee Ng; Abigail Peck; Rachel S Lee; Sandy Hung; Megan V Astle; Megan Bywater; Meaghan Wall; Gretchen Poortinga; Katarzyna Jastrzebski; Karen E Sheppard; Brian A Hemmings; Michael N Hall; Ricky W Johnstone; Grant A McArthur; Ross D Hannan; Richard B Pearson
Journal:  Sci Signal       Date:  2011-08-30       Impact factor: 8.192

3.  AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR.

Authors:  R A Laskowski; J A Rullmannn; M W MacArthur; R Kaptein; J M Thornton
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

4.  RPL21 siRNA Blocks Proliferation in Pancreatic Cancer Cells by Inhibiting DNA Replication and Inducing G1 Arrest and Apoptosis.

Authors:  Chaodong Li; Mei Ge; Daijie Chen; Tao Sun; Hua Jiang; Yueqing Xie; Huili Lu; Baohong Zhang; Lei Han; Junsheng Chen; Jianwei Zhu
Journal:  Front Oncol       Date:  2020-09-08       Impact factor: 6.244

5.  Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.

Authors:  Zichen Zhang; Guan-Hua Lai; Alphonse E Sirica
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

6.  The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.

Authors:  Tong Wu; Jing Leng; Chang Han; Anthony Jake Demetris
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

7.  Up-regulated of Angiopoietin-Like Protein 4 Predicts Poor Prognosis in Cervical Cancer.

Authors:  Dan Nie; Qianwen Zheng; Ling Liu; Xiguang Mao; Zhengyu Li
Journal:  J Cancer       Date:  2019-04-21       Impact factor: 4.207

8.  Curcumin enhances chemotherapeutic effects and suppresses ANGPTL4 in anoikis-resistant cholangiocarcinoma cells.

Authors:  Tin Tin San; Prasong Khaenam; Virapong Prachayasittikul; Banchob Sripa; Nawapol Kunkeaw; Waraporn Chan-On
Journal:  Heliyon       Date:  2020-01-30

9.  Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients.

Authors:  Tin May Aung; Mang Ngaih Ciin; Atit Silsirivanit; Apinya Jusakul; Worachart Lert-Itthiporn; Tanakorn Proungvitaya; Sittiruk Roytrakul; Siriporn Proungvitaya
Journal:  Front Public Health       Date:  2022-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.